Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) reported Q4 GAAP EPS of $0.42, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $20.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
